Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients

Due to heterogeneous multifocal nature of prostate cancer (PCa), there is currently a lack of biomarkers that stably distinguish it from benign prostatic hyperplasia (BPH), predict clinical outcome and guide the choice of optimal treatment. In this study RNA-seq analysis was applied to formalin-fixe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikitina, Anastasia S., Sharova, Elena I., Danilenko, Svetlana A., Butusova, Tatiana B., Vasiliev, Alexandr O., Govorov, Alexandr V., Prilepskaya, Elena A., Pushkar, Dmitry Y., Kostryukova, Elena S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464844/
https://www.ncbi.nlm.nih.gov/pubmed/28380430
http://dx.doi.org/10.18632/oncotarget.16518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464844/
https://www.ncbi.nlm.nih.gov/pubmed/28380430
http://dx.doi.org/10.18632/oncotarget.16518

Ejemplares similares